510(k) Report

510(k) · Decided

Recalled · 2005

Modification to Omnilink .035 Biliary Stent System

K032530510(k) SpecialDecided Oct 23, 200369-day reviewClass II21 CFR 876.5010Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Guidant Corporation · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Oct 23, 2003 as substantially equivalent to K011506 (Guidant Corp., 2001) after a 69-day review. Its family tree reaches back 1 generation to 2001. 3 later devices descend from it. It has been recalled once.

Decided
Oct 23, 2003
Review
69 days
Class
Class II
Product code
FGE
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K011506 (2001). 3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2006: 2 descendants cleared2004: 1 descendant clearedK011506 · Omnilink .035 Biliary Stent System · Guidant Corp. · 2001 · recalled200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 1 descendant K011506 · Omnilink .035 Biliary Stent System · Guidant Corp. · 2001 · recalled0
  1. Root · 1 generation backK011506 Omnilink .035 Biliary Stent SystemGuidant Corp. · 2001 · Recalled
  2. This deviceK032530 Modification to Omnilink .035 Biliary Stent SystemGuidant Corporation · 2003
  3. Descendant · cites it directly · 1 of its ownK033834 Omnilink .018 Biliary Stent SystemGuidant Corp. · 2004 · Recalled
  4. Descendant · 2 generations on · 0 of its ownK060817 Omnilink. 018 Biliary Stent SystemGuidant Endovascular Solutions, Inc. · 2006
  5. Descendant · cites it directly · 0 of its ownK053459 Omnilink .035 Biliary Stent SystemGuidant Corporation · 2006

Most influential descendants

Showing 3 of 3 · See all
  • K033834Omnilink .018 Biliary Stent SystemGuidant Corp. · 2004 · cites it directly1descendant
  • K060817Omnilink. 018 Biliary Stent SystemGuidant Endovascular Solutions, Inc. · 2006 · 2 generations on0descendants
  • K053459Omnilink .035 Biliary Stent SystemGuidant Corporation · 2006 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K011506Omnilink .035 Biliary Stent SystemGuidant Corp.20011
0 (this device)K032530Modification to Omnilink .035 Biliary Stent SystemGuidant Corporation2003—
+1K033834Omnilink .018 Biliary Stent SystemGuidant Corp.20041
+2K060817Omnilink. 018 Biliary Stent SystemGuidant Endovascular Solutions, Inc.2006—
+1K053459Omnilink .035 Biliary Stent SystemGuidant Corporation2006—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200620
FIG. 1 — Lineage of K032530, 2001–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011506Omnilink .035 Biliary Stent SystemGuidant Corp.20011

Also cleared against K011506: 1 other device →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K033834Omnilink .018 Biliary Stent SystemGuidant Corp.20041
K053459Omnilink .035 Biliary Stent SystemGuidant Corporation20060

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 8, 2005Not classifiedZ-1586-05OtherThis action is being taken as a preventative measure as a result of an increased rate of complaints associated with stents becoming loose or dislodged from the delivery catheter.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K033834 (Guidant Corp., 2004) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K011506.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

[email protected] Biliary Stent System is intended as a palliative treatment of malignant neoplasms in the biliary tree.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032530: Modification to Omnilink .035 Biliary Stent System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032530

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026